Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer
A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most ...
Miracle leukaemia drug trial offers fresh hope to new cancer patients
A leukaemia patient told the Daily Express of his six-year cancer-free miracle, thanks to a new drug trial offering fresh ...
Frontiers11h
Advancing Precision Medicine in Lung Cancer: Integrating Genomics, Liquid Biopsy and Novel Diagnostic Tools
Precision medicine in the context of lung cancer represents a transformative approach that integrates prevention, diagnosis, and treatment tailored to individual patient differences. This field ...
AlphaGalileo11h
New Method Improves Treatment for Leukemia and Lung Cancer
A new method can improve treatment for patients with chronic myeloid leukaemia by predicting which medication will be most effective. The method also works for other forms of cancer where resistance ...
Cure Today21h
FDA Grants Breakthrough Therapy Designation to Sac-TMT for Some with NSCLC
The FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for patients with advanced or metastatic ...
Merck Receives FDA Breakthrough Therapy Designation for Investigational Lung Cancer Treatment
Merck ( MRK, Financials) stated that sacituzumab tirumotecan (sac-TMT) was designated a Breakthrough Therapy by the FDA for advanced or metastatic nonsquamous non-small cell lung cancer with epidermal ...